期刊文献+

K-B法和三维分析法测定阴沟肠杆菌AmpC酶结果分析 被引量:7

Kirby-Bauer Method and Three-dimensional Test Detected AmpC Enzyme in Enterobacter cloacae: Analysis of Results
下载PDF
导出
摘要 目的 探讨阴沟肠杆菌Kirby Bauer(K B)法推测与三维分析法测定AmpC酶的相关性。方法 用K B法测定细菌耐药谱用三维分析法和三维抑制法测定阴沟肠杆菌菌株粗提物中的AmpC酶。结果  12 4株阴沟肠杆菌从耐药谱分析可疑高产AmpC酶为 32株 ,其中三维及三维抑制法证实 2 4株 ( 75 %)为持续高产AmpC酶株 ,7株为ESBLs(extended spectrumβ lactamases) ( +) ,2株为SSBL( +) ,即为持续高产AmpC酶株 ,又为ESBLs阳性株。结论 从K B法推测高产AmpC酶有 75 %相关性。 OBJECTIVE To explore the correlation of Kirby-Bauer(K-B) method and three-dimensional test to detect AmpC enzyme in Enterobacter cloacae. METHODS To use K-B method to detect resistance spectrum of E. cloacae and three-dimensional test and three-dimensional inhibition test to detect AmpC enzyme in isolates of E.cloacae. RESULTS Among 124 strains of E.cloacae, 32 strains were suspected to hyperproducting AmpC enzyme, 24 strains were proved to hyperproduct strains by three-dimensional test in 32 strains; 7 strains were ESBLs ( extended-spectrum β-lactamases) -producing; 2 strains were SSBL(+) (both hyperproducting AmpC enzyme and ESBLs producing). CONCLUSIONS The correlativity is 75% from K-B method supposed hyperproducting AmpC enzyme.
机构地区 北京石景山医院
出处 《中华医院感染学杂志》 CAS CSCD 2003年第4期391-392,共2页 Chinese Journal of Nosocomiology
关键词 阴沟肠杆菌 Kirby-Bauer法 三维抑制法 AMPC酶 耐药性 医院感染 抗生素 Enterobacter cloacae Kirby-Bauer method three-dimensional test and three-dimensional inhibition test AmpC enzyme
  • 相关文献

参考文献6

二级参考文献43

  • 1Bennett PM, Chopra I. Molecular basis of β-lactamase induction in bacteria[J]. Antimicrob Agents Chemother, 1993, 37(2): 153-158.
  • 2Sanders CC, Bradford PA, Ehrhardt AF et al. Penicillin-binding proteins and induction of AmpC β-lactamase[J]. Antimicrob Agents Chemother, 1997, 41(9): 2013-2015.
  • 3Jones RN. Important and emerging β-lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymes[J]. Diagn Microbiol Infect Dis, 1998, 31(3): 461-446.
  • 4Haruta S, Nukaga M, Taniguchi K et al. Resistance to oxyimino β-lactams due to a mutation of chromosomal β-lactamase in Citrobacter freundii[J]. Microbiol Immuno, 1998, 42(3): 165-169.
  • 5Korfmann G, Sanders CC, Moland ES. Alterd phenotypes associated with ampD mutations in E. cloacae[J]. Antimicrob Agents Chemother, 1991, 35(2): 358-364.
  • 6Bartowsky E, Normark S. Purification and mutant analysis of Citrobacter freundii AmpR: the regulator for chromosomal AmpC β-lactamase[J]. Mol Microbiol, 1991,5(7): 1715-1725.
  • 7Stapleton P, Shannon K, Phillips I. DNA sequence differences of ampD mutants of Citrobacter freundii[J]. Antimicrob Agents Chemother, 1995, 39(11): 2494-2498.
  • 8Bush K , Jacoby GA, Mederios AA. A functional classification scheme for β-lactamases and its correlation with molecular structure[J]. Antimicrob Agents Chemother, 1995, 39(6): 1211-1233.
  • 9Papanicolaou GA, Mederios AA, Jacoby GA. Novel plasmid-mediatedβ-lactamase (MIR-1) conferring resistance to oxyimino-and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 1990, 34(11): 2200-2209.
  • 10Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamases in Klebsiella pneumoniae including resistance to cephamycins[J]. Infection, 1989, 17(5): 316-321.

共引文献266

同被引文献46

引证文献7

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部